Vincent Fradet

Summary

Publications

  1. ncbi Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging
    Vincent Fradet
    Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, Calif, USA
    Radiology 256:176-83. 2010
  2. ncbi Urologist density and county-level urologic cancer mortality
    Anobel Y Odisho
    Department of Urology, University of California, San Francisco, San Francisco, CA 94143 1695, USA
    J Clin Oncol 28:2499-504. 2010
  3. ncbi Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California 94115, USA
    J Urol 186:2228-32. 2011
  4. ncbi Pathological outcomes of candidates for active surveillance of prostate cancer
    Simon L Conti
    Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA
    J Urol 181:1628-33; discussion 1633-4. 2009
  5. ncbi Penile sonographic and clinical characteristics in men with Peyronie's disease
    James F Smith
    University of California Department of Urology, 1600 Divisadero, Box 1695, San Francisco, CA 94143, USA
    J Sex Med 6:2858-67. 2009
  6. ncbi Geographic distribution of urologists throughout the United States using a county level approach
    Anobel Y Odisho
    Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    J Urol 181:760-5; discussion 765-6. 2009
  7. ncbi Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer
    Adam C Reese
    Department of Urology, University of California San Francisco, CA 94158, USA
    J Nutrigenet Nutrigenomics 2:149-58. 2009
  8. ncbi Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk
    Vincent Fradet
    Departments of Urology, Institute for Human Genetics, University of California at San Francisco, San Francisco, California 94143 0794, USA
    Clin Cancer Res 15:2559-66. 2009

Collaborators

Detail Information

Publications8

  1. ncbi Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging
    Vincent Fradet
    Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, Calif, USA
    Radiology 256:176-83. 2010
    ....
  2. ncbi Urologist density and county-level urologic cancer mortality
    Anobel Y Odisho
    Department of Urology, University of California, San Francisco, San Francisco, CA 94143 1695, USA
    J Clin Oncol 28:2499-504. 2010
    ..The goal of this study was to determine the effect of increasing urologist density on local prostate, bladder, and kidney cancer mortality...
  3. ncbi Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California 94115, USA
    J Urol 186:2228-32. 2011
    ..2 ng/ml) accurately reflects measures performed in the traditional range (prostate specific antigen greater than 0.2 ng/ml)...
  4. ncbi Pathological outcomes of candidates for active surveillance of prostate cancer
    Simon L Conti
    Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA
    J Urol 181:1628-33; discussion 1633-4. 2009
    ..We evaluated the pathological outcomes of men meeting published criteria for active surveillance who elected immediate radical prostatectomy to assess the risk of under grading and under staging in candidates for active surveillance...
  5. ncbi Penile sonographic and clinical characteristics in men with Peyronie's disease
    James F Smith
    University of California Department of Urology, 1600 Divisadero, Box 1695, San Francisco, CA 94143, USA
    J Sex Med 6:2858-67. 2009
    ..Ultrasonography of the penis is readily available to the urologist and gives good anatomic detail of soft tissue structures. It has not been widely utilized in the assessment of Peyronie's disease (PD)...
  6. ncbi Geographic distribution of urologists throughout the United States using a county level approach
    Anobel Y Odisho
    Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    J Urol 181:760-5; discussion 765-6. 2009
    ..We assessed the geographic distribution of urologists throughout the United States at the county level and determined the county characteristics associated with increased urologist density...
  7. ncbi Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer
    Adam C Reese
    Department of Urology, University of California San Francisco, CA 94158, USA
    J Nutrigenet Nutrigenomics 2:149-58. 2009
    ..Overall, results to date support the hypothesis that long-chain omega-3 PUFAs may impact prostate inflammation and carcinogenesis via the COX-2 enzymatic pathway...
  8. ncbi Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk
    Vincent Fradet
    Departments of Urology, Institute for Human Genetics, University of California at San Francisco, San Francisco, California 94143 0794, USA
    Clin Cancer Res 15:2559-66. 2009
    ..This potential effect may be modified by genetic variation in cyclooxygenase-2 (COX-2), a key enzyme in fatty acid metabolism and inflammation...